Applied Therapeutics Reports Fourth Quarter and Year-end 2019 Financial Results

by NASDAQ Market News March 13, 2020

NASDAQ Market News
Click here to email author

I-Mab Biopharma Announces Development of TJM2 to Treat Cytokine Release Syndrome Associated with Severe and Critically-Ill Patients with Coronavirus Disease (COVID-19)

AB Science will present results from its Phase 3 AB07015 study in severe asthma at the 2020 American Thoracic Society International Conference

Ads